Concepedia

Publication | Open Access

Improvement in Disease Activity in Refractory Juvenile Dermatomyositis Following Abatacept Therapy

24

Citations

23

References

2023

Year

Abstract

This open-label study demonstrated that abatacept may be beneficial for patients with treatment-refractory juvenile DM.

References

YearCitations

Page 1